+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Polichemotherapy of advanced head and neck malignancies

Polichemotherapy of advanced head and neck malignancies

Tumori 62(6): 599-608

The favorable results obtained by other authors with polichemotherapy encouraged us to employ therapeutic scheme using a combination of 4 drugs. Treatment envolved the administration of 300 mg/mz cyclophosphamide, 350 mg/m2 5-fluorouracil, 10 mg/mw2 methotrexate i.v. on alternate days 6-8 times, and 15 mg bleomycin on alternate days until a total dose of 150-200 mg is reached. Thirty-five out of 37 patients treated with this protocol (30 previously treated and 5 not) qualified for analysis; the site of the neoplasm, mostly squamous cell carcinoma, was different; for the most part it was in the larynx (18/35) and the oral cavity (10/35). Complete remission was achieved in 9/35 patients (25.7%), varying from 5 to 33 months (median 22); partial remission was achieved in 15/35 cases (42.8%), varying from 1 to 14 months (median 3); and there was no success in 11/35 cases (31.5%). Overall, a total remission greater than 50% was observed in 24/35 patients (68.5%). The most serious side effects both ascribed to BLM were observed in the central nervous system (increasing drowsiness and coma) and the lung. This study has shown that in the ultra head and neck malignancies medical treatment can achieve satisfactory results.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 038967709

Download citation: RISBibTeXText

PMID: 67688

Related references

Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 78(2): 61-69, 2016

Systemic chemotherapy of advanced head and neck malignancies. Cancer 35(4): 1116-1120, 1975

Immuno competence in patients with advanced head and neck malignancies. Otologia Fukuoka 28(SUPPL): 430-436, 1982

Continuous hyperfractionated accelerated radiotherapy in advanced head and neck malignancies. Indian Journal of Cancer 35(1): 19-26, 1998

Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. Journal of Clinical Oncology 5(10): 1601-1606, 1987

Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies. Journal of Cancer Research and Therapeutics 1(1): 46-50, 2007

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head & Neck 14(5): 364-371, 1992

Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies. Laryngoscope 100(3): 237-239, 1990

Management of carotid artery invasion in advanced malignancies of head and neck comparison of techniques. Annals of Otology, Rhinology, and Laryngology 111(9): 772-777, 2002

Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. International Journal Of Radiation Oncology Biology Physics. 25(4): 657-660, 1993

Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies. International Journal of Radiation Oncology Biology Physics 42(5): 1085-1089, Dec 1, 1998

CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. Journal of Vascular and Interventional Radiology 19(5): 725-735, 2008

Advanced head and neck cancer, long term results of chemoradiotherapy, complications and induction of second malignancies. Onkologie 23(Sonderheft 7): 174, October, 2000